XLO · Company research
Xilio Therapeutics, Inc. (XLO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 9 | $146,111,025.14 | -4221974.8636 | — | — | — | 11.5521050866856420 | 2.0140743695140947 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.